FABP4 and ovarian carcinoma: The upregulation of FABP4 is closely associated with enhanced proliferation, migration, and epithelial‐mesenchymal transition (EMT) capacity of cancer cells such as breast, prostate, and ovarian cancer.16, 17, 18